OBJECTIVE: To investigate the association between migraine and hypertension in the Northern Manhattan Study (NOMAS), a multiethnic community-based sample. DESIGN: Cross-sectional cohort study. PARTICIPANTS: 1338 NOMAS participants (mean age 68.1 ± 9.6 years, 37% male, 15% non-Hispanic White, 19% non-Hispanic Black, 67% Hispanic). SETTING: Northern Manhattan community. INTERVENTION: Participants were assessed for migraine symptoms using a self-report questionnaire based on criteria from the International Classification of Headache Disorders. Hypertension was defined as blood pressure ≥140/90 mm Hg, the patient's self-reported hypertension, or use of anti-hypertensive medications. Duration (≤9 years vs >9 years) and control (BP<140/90) of hypertension were examined. We estimated the association between hypertension and migraine (overall and with/without aura) using logistic regression, adjusting for sociodemographic and vascular risk factors. RESULTS: The majority of participants (80%) had no migraine, 6% had migraine with aura, and 15% had migraine without aura. Hypertension was present in 76% of the study population (7% had controlled hypertension ≤9 years duration, 5% controlled hypertension >9 years duration, 41% uncontrolled hypertension ≤9 years duration, 23% uncontrolled hypertension >9 years duration). Hypertension was associated with migraine (OR: 1.76, 95% CI: 1.21-2.54), both with and without aura. This association was particularly apparent for those with uncontrolled and long duration hypertension. CONCLUSION: Hypertension, particularly uncontrolled and of long duration, is associated with migraine, both with and without aura, in a predominantly Hispanic community-based cohort.
OBJECTIVE: To investigate the association between migraine and hypertension in the Northern Manhattan Study (NOMAS), a multiethnic community-based sample. DESIGN: Cross-sectional cohort study. PARTICIPANTS: 1338 NOMAS participants (mean age 68.1 ± 9.6 years, 37% male, 15% non-Hispanic White, 19% non-Hispanic Black, 67% Hispanic). SETTING: Northern Manhattan community. INTERVENTION: Participants were assessed for migraine symptoms using a self-report questionnaire based on criteria from the International Classification of Headache Disorders. Hypertension was defined as blood pressure ≥140/90 mm Hg, the patient's self-reported hypertension, or use of anti-hypertensive medications. Duration (≤9 years vs >9 years) and control (BP<140/90) of hypertension were examined. We estimated the association between hypertension and migraine (overall and with/without aura) using logistic regression, adjusting for sociodemographic and vascular risk factors. RESULTS: The majority of participants (80%) had no migraine, 6% had migraine with aura, and 15% had migraine without aura. Hypertension was present in 76% of the study population (7% had controlled hypertension ≤9 years duration, 5% controlled hypertension >9 years duration, 41% uncontrolled hypertension ≤9 years duration, 23% uncontrolled hypertension >9 years duration). Hypertension was associated with migraine (OR: 1.76, 95% CI: 1.21-2.54), both with and without aura. This association was particularly apparent for those with uncontrolled and long duration hypertension. CONCLUSION:Hypertension, particularly uncontrolled and of long duration, is associated with migraine, both with and without aura, in a predominantly Hispanic community-based cohort.
Authors: April P Carson; George Howard; Gregory L Burke; Steven Shea; Emily B Levitan; Paul Muntner Journal: Hypertension Date: 2011-04-18 Impact factor: 10.190
Authors: Chuanhui Dong; David Della-Morte; Tatjana Rundek; Clinton B Wright; Mitchell S V Elkind; Ralph L Sacco Journal: Hypertension Date: 2016-02-01 Impact factor: 10.190
Authors: Mika Kivimäki; Markus Jokela; Solja T Nyberg; Archana Singh-Manoux; Eleonor I Fransson; Lars Alfredsson; Jakob B Bjorner; Marianne Borritz; Hermann Burr; Annalisa Casini; Els Clays; Dirk De Bacquer; Nico Dragano; Raimund Erbel; Goedele A Geuskens; Mark Hamer; Wendela E Hooftman; Irene L Houtman; Karl-Heinz Jöckel; France Kittel; Anders Knutsson; Markku Koskenvuo; Thorsten Lunau; Ida E H Madsen; Martin L Nielsen; Maria Nordin; Tuula Oksanen; Jan H Pejtersen; Jaana Pentti; Reiner Rugulies; Paula Salo; Martin J Shipley; Johannes Siegrist; Andrew Steptoe; Sakari B Suominen; Töres Theorell; Jussi Vahtera; Peter J M Westerholm; Hugo Westerlund; Dermot O'Reilly; Meena Kumari; G David Batty; Jane E Ferrie; Marianna Virtanen Journal: Lancet Date: 2015-08-19 Impact factor: 79.321